Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018
Health Populi
JUNE 5, 2018
” A genetic test that costs $3,000 helps to identify women who could benefit from avoiding chemo. The test is called the Oncotype DX Breast Recurrence Score. The second chart illustrates patient-borne costs for early stage breast cancer.
Let's personalize your content